ORAFOL has announced global expansion projects for the next five years. ‘ORAFOL Roadmap 2030 – Shaping the Future’ is based on a €235 million investment initiative for the period 2026–2030 at its headquarters in Oranienburg, as well as additional expansion projects in the sales regions of Europe, North and South America and Asia-Pacific.
In doing so, the technology company underscores its role in its home region as a reliable partner for local businesses and as a driver of growth. At the same time, the roadmap reflects the need for ORAFOL to continuously invest in newly developed sustainable technologies in order to secure and expand its international competitiveness.
Dr. Holger Loclair, Chairman & CEO of the ORAFOL Group, said: “The ORAFOL Roadmap 2030, with its investment initiative, reflects my optimism and represents a commitment to our home base in Germany. At the same time, we have built up the strength to consistently pursue our growth globally through investments. Both are crucial to our goal of remaining one of the market leaders.”
In addition to the planned €235 million (2026–2030) at the company’s headquarters, the ‘ORAFOL Roadmap 2030 – Shaping the Future’ calls for further significant expansion investments, including at the subsidiaries ORAFOL Americas in the U.S., Group M.A.M. in Belgium, and Reflomax in Korea. In this context, a Letter of Intent (LOI) was formally signed with representatives of the Korean province of Gyeonggi at the headquarters on April 2, 2026. This LOI provides for an investment of more than $60 million for the first expansion phase of an ORAFOL production plant in the Seoul region of Korea.
ORAFOL had already announced investments totalling €150 million by 2027 as early as 2025. Through this significant expansion of its investment plans for 2028, 2029 and 2030, the company is sending a strong signal of long-term security – not only for its own market activities but also for Brandenburg as an industrial hub and the company’s employees. The ORAFOL Roadmap also enhances planning certainty for the technology and development partners of this globally active family-owned company across the entire value chain – particularly in a challenging market environment, this ensures stability.
Caption:
Dr Holger Loclair, Chairman & Chief Executive Officer, Orafol